Medicare Enrolled

Dr. Benjamin Barnes, MD

Neuromuscular Medicine (Psychiatry & Neurology) Physician · Augusta, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1120 15TH ST, Augusta, GA 30912
7067213813
In practice since 2015 (11 years)
NPI: 1760866545 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Barnes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barnes? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Barnes

Dr. Benjamin Barnes is a neuromuscular medicine physician in Augusta, GA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Barnes performed 323 Medicare services across 237 unique beneficiaries.

Between the years covered by Open Payments, Dr. Barnes received a total of $47,942 from 45 pharmaceutical and/or device companies across 300 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neuromuscular medicine (psychiatry & neurology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Barnes is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ 323 Medicare services $47,942 industry payments

Medicare Practice Summary

Medicare Utilization ↗
323
Medicare services
Bottom 33% in GA for neuromuscular medicine (psychiatry & neurology) physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
237
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~29 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
59 $13 $43
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
44 $58 $152
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
35 $31 $114
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 33 $15 $76
Chemical nerve block injection, 5+ arm/leg muscles
Injection of a chemical agent to paralyze five or more muscles in the first extremity treated.
29 $85 $286
Nerve conduction study, 3-4 tests
A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function.
29 $47 $155
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
26 $24 $71
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
23 $58 $135
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
20 $87 $311
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $85 $226
New patient office visit, complex (60-74 min) 11 $146 $445
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$47,942
Total received (2019-2024)
Avg $7,990/year across 6 years
Top 0% in GA for neuromuscular medicine (psychiatry & neurology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
300
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$36,677 (76.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,252 (13.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,013 (10.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,952
2023
$7,853
2022
$28,957
2021
$7,511
2020
$1,618
2019
$50

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$295
MITSUBISHI TANABE PHARMA AMERICA, INC.
$243
ABBVIE INC.
$196
ARGENX US, INC.
$172
Alnylam Pharmaceuticals Inc.
$125
Teva Pharmaceuticals USA, Inc.
$120
UCB, Inc.
$118
Ipsen Biopharmaceuticals, Inc
$93
AstraZeneca Pharmaceuticals LP
$88
Takeda Pharmaceuticals U.S.A., Inc.
$85
CSL Behring
$61
Neurocrine Biosciences, Inc.
$56
Merz Pharmaceuticals, LLC
$50
PFIZER INC.
$48
REVANCE THERAPEUTICS, INC.
$45
Genentech USA, Inc.
$38
Averitas Pharma Inc.
$27
Amicus Therapeutics, Inc.
$22
Kedrion Biopharma, Inc.
$21
Grifols USA, LLC
$19
Neurelis, Inc.
$15
Octapharma USA, Inc.
$14
Top 3 companies account for 37.6% of 2024 payments
All-time payments by company (2019-2024) ›
Biogen, Inc.
$38,127
ARGENX US, INC.
$4,000
Alexion Pharmaceuticals, Inc.
$1,144
MITSUBISHI TANABE PHARMA AMERICA, INC.
$588
Teva Pharmaceuticals USA, Inc.
$367
Neurocrine Biosciences, Inc.
$324
AbbVie Inc.
$276
ABBVIE INC.
$229
Ipsen Biopharmaceuticals, Inc
$210
UCB, Inc.
$203
Takeda Pharmaceuticals U.S.A., Inc.
$196
Amylyx Pharmaceuticals, Inc.
$174
Merz Pharmaceuticals, LLC
$172
Otsuka America Pharmaceutical, Inc.
$162
Alnylam Pharmaceuticals Inc.
$155
SK Life Science, Inc.
$155
PFIZER INC.
$139
Genentech USA, Inc.
$122
CSL Behring
$115
Akcea Therapeutics, Inc.
$115
Amgen Inc.
$98
AstraZeneca Pharmaceuticals LP
$88
Biohaven Pharmaceutical Holding Company Ltd.
$69
Allergan, Inc.
$60
GENZYME CORPORATION
$57
JAZZ PHARMACEUTICALS INC.
$53
EISAI INC.
$51
Neurelis, Inc.
$46
HOSPIRA, INC.
$45
REVANCE THERAPEUTICS, INC.
$45
Eisai Inc.
$44
Jazz Pharmaceuticals Inc.
$43
Grifols USA, LLC
$32
Averitas Pharma Inc.
$27
Avion Pharmaceuticals
$25
Lundbeck LLC
$24
Greenwich Biosciences, Inc.
$23
Amicus Therapeutics, Inc.
$22
Kedrion Biopharma, Inc.
$21
Adamas Pharmaceuticals, Inc.
$19
Avanir Pharmaceuticals, Inc.
$18
Baxter Healthcare
$17
E.R. Squibb & Sons, L.L.C.
$17
Octapharma USA, Inc.
$14
NATUS MEDICAL INCORPORATED
$11
Top 3 companies account for 90.3% of all-time payments
Associated products mentioned in payments ›
AJOVY · AMVUTTRA · AUSTEDO · Aimovig · Albuked · Austedo XR · BOTOX · Briviact · DAXXIFY · DYSPORT · Dhivy · Dysport · ELIQUIS · EPIDIOLEX · Epidiolex · Evrysdi · Fycompa · GOCOVRI · Gamunex-C · HYQVIA · Hizentra · INGREZZA · NEXVIAZYME · NUEDEXTA · NURTEC ODT · Nuedexta · ONPATTRO · Ongentys · PANZYGA · Pombiliti · QULIPTA · QUTENZA · RADICAVA · RELYVRIO · REXULTI · Radicava · Rystiggo · SOLIRIS · SPINRAZA · Soliris · Spinraza · TEGSEDI · UBRELVY · ULTOMIRIS · VALTOCO · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · XYWAV · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neuromuscular medicine (psychiatry & neurology) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for neuromuscular medicine (psychiatry & neurology) physician in GA.

Looking for a neuromuscular medicine physician in Augusta?
Compare neuromuscular medicine physicians in the Augusta area by procedure volume, costs, and industry payment transparency.
Browse neuromuscular medicine physicians nearby

Geographic Context

Neuromuscular medicine physicians within 10 mi
1
Per 100K population
0.5
County median income
$53,197
Nearest hospital
WELLSTAR MCG HEALTH, AFFILIATED WITH MED COL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Barnes is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of GA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Barnes experienced with limited needle emg of arm or leg muscles?
Based on Medicare claims data, Dr. Barnes performed 59 limited needle emg of arm or leg muscles services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Barnes receive payments from pharmaceutical companies?
Yes. Dr. Barnes received a total of $47,942 from 45 companies across 300 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barnes's costs compare to other neuromuscular medicine physicians in Augusta?
Dr. Barnes's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barnes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →